Kymera Therapeutics, Inc. Contracts & Agreements
25 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (5)
- Human Resources (5)
- Real Estate (1)
- Uncategorized (1)
- Form of Pre-Funded Warrant (Filed With SEC on January 5, 2024)
- Underwriting Agreement, dated January 4, 2024, by and among Kymera Therapeutics, Inc. and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC (Filed With SEC on January 5, 2024)
- Registration Rights Agreement, dated August 18, 2022, by and among Kymera Therapeutics, Inc. and the persons party thereto (Filed With SEC on August 19, 2022)
- Securities Purchase Agreement, dated August 18, 2022, by and among Kymera Therapeutics, Inc. and the persons party thereto (Filed With SEC on August 19, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 19, 2022)
- Second Amendment to Master Collaboration Agreement between the Registrant and Vertex Pharmaceuticals Incorporated, dated as of October 21, 2021 (Filed With SEC on February 24, 2022)
- Amended and Restated Non-Employee Director Compensation Policy dated January 17, 2022 (Filed With SEC on February 24, 2022)
- Form of Underwriting Agreement (Filed With SEC on June 28, 2021)
- Description of Securities (Filed With SEC on March 11, 2021)
- First Amendment to Master Collaboration Agreement between the Registrant and Vertex Pharmaceuticals Incorporated, dated as of August 27, 2020 (Filed With SEC on November 5, 2020)
- First Amendment to Collaboration Agreement between the Registrant and GlaxoSmithKline Intellectual Property Development Limited, dated as of August 27, 2020 (Filed With SEC on November 5, 2020)
- Amended and Restated 2020 Employee Stock Purchase Plan (Filed With SEC on November 5, 2020)
- Form of Common Stock Purchase Agreement between the Registrant and Vertex Pharmaceuticals Incorporated (Filed With SEC on August 17, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on August 17, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on August 17, 2020)
- 2020 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on August 17, 2020)
- Specimen Common Stock Certificate (Filed With SEC on August 17, 2020)
- Form of Underwriting Agreement (Filed With SEC on August 17, 2020)
- Form of Amended and Restated Employment Agreement (Filed With SEC on August 13, 2020)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on August 13, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on August 13, 2020)
- Collaboration Agreement between the Registrant and GlaxoSmithKline Intellectual Property Development Limited, dated as of October 3, 2017 (Filed With SEC on August 5, 2020)
- Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of March 11, 2020 (Filed With SEC on July 31, 2020)
- Lease Agreement between the Registrant and ARE-TECH SQUARE, LLC, dated as of February 28, 2018 (Filed With SEC on July 31, 2020)
- 2018 Stock Option and Grant Plan, and form of award agreements thereunder (Filed With SEC on July 31, 2020)